$CGEM News Article - Cullinan Therapeutics to Pres
Post# of 15
(Total Views: 70)
Posted On: 04/24/2024 12:10:50 PM
$CGEM News Article - Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024 | Benzinga https://marketwirenews.com/news-releases/cull...05740.html
(0)
(0)Consolidated Gems, Inc. (CGEM) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼